Nikao Life Sciences provides expert guidance across a broad range of administration routes, ensuring study designs, safety evaluations, and regulatory strategies are aligned with route-specific considerations. Our expertise supports feasibility assessment, species selection, local and systemic toxicity evaluation, exposure justification, and regulatory expectations.
Regulatory Frameworks
Expert knowledge across international regulatory bodies and guidance documents, including:
- FDA, EMA, MHRA, PMDA, and Health Canada
- ICH S-series (S1–S12) toxicology and safety guidelines
- GLP compliance requirements and interpretation
- SEND requirements, dataset integration, and submission alignment
We ensure your program meets the expectations of each agency while maintaining a unified global strategy.
Submission Readiness
End-to-end support for the preparation and quality of nonclinical regulatory deliverables:
- IND / CTA preparation and strategy
- NDA / BLA / MAA nonclinical components
- Investigator’s Brochures (IBs) and updates
- Briefing documents and pre-meeting packages
- Regulatory interaction planning and support
Our teams ensure scientific accuracy, internal consistency, and regulatory defensibility across all documents.
Cross-Functional Alignment
A complete integration of data and messaging across disciplines:
- Nonclinical
- Clinical
- CMC
- Quality
- Program management
This ensures your submission tells a cohesive scientific story, eliminates contradictions, and strengthens your regulatory position.
